Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for Alpharma Brand of Molsidomine Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Alpharma Brand of Molsidomine

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,324Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    26/09/2024 Allessa GmbH
    Germany
    		 ALLESSA GMBH FRANKFURT DE CEP 2017-214 - Rev 01 Molsidomine 2024-01-05 Valid Chemical 1701
    26/09/2024 XYZ Pharma
    Gabon
    		 ZAKŁADY FARMACEUTYCZNE POLPHARMA S... CEP 2017-021 - Rev 01 Molsidomine 2024-03-25 Valid Chemical 1701